Compound information
- Natural Products
- NACP62884
- Molecular Formula
- C21H20O5
- Molecular Weight
- 352.13107374 g/mol
- Structure
-
- IUPAC Name
- 1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one
- InChI
- InChI=1S/C21H20O5/c1-25-20-13-15(8-11-18(20)23)5-3-4-6-17(22)10-7-16-9-12-19(24)21(14-16)26-2/h3-14,23-24H,1-2H3
- InChI Key
- JUDCTVXWYFNGQQ-UHFFFAOYSA-N
- SMILES
- O=C(C=CC=CC1=CC=C(O)C(OC)=C1)C=CC2=CC=C(O)C(OC)=C2
- CAS
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Diarylheptanoids
- SubClass
- Linear diarylheptanoids
- Source
- CNP0184158
Warheads
- Michael Acceptor
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.99 Å2 | LogP | 3.735 |
LogS | -6.184 | LogD | 3.749 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.551 | Pgp substrate | 0.001 |
HIA | 0.96 | F20 % | 0.967 |
F30 % | 0.826 | Caco-2 | -5.004 |
MDCK | -4.692 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.017 | PPB | 81.851 |
VD | 0.855 | Fu | 1.589 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.98 | CYP1A2 substrate | 0.81 |
CYP2A6 substrate | 0.756 | CYP2B6 substrate | 0.593 |
CYP2C19 inhibitor | 0.256 | CYP2C19 substrate | 0.719 |
CYP2C8 substrate | 0.765 | CYP2C9 inhibitor | 0.684 |
CYP2C9 substrate | 0.599 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.825 | CYP2E1 substrate | 0.324 |
CYP3A4 inhibitor | 0.604 | CYP3A4 substrate | 0.142 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.918 | CL | 11.547 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.143 | Hepatotoxicity | 0.052 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.205 |
FDAMDD | 0.96 | Skin Sensitization | 0.994 |
Carcinogenicity | 0.134 | Eye Corrosion | 0.001 |
Eye Irritation | 0.941 | Respiratory Toxicity | 0.662 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.623 | IGC50 | 6.389 |
LC50FM | 7.275 | LC50DM | 5.718 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.252 | NR-AR-LBD | 0.897 |
NR-AhR | 0.764 | NR-Aromatase | 0.888 |
NR-ER | 0.813 | NR-ER-LBD | 0.833 |
NR-PPAR-gamma | 0.973 | SR-ARE | 0.965 |
SR-ATAD5 | 0.892 | SR-HSE | 0.972 |
SR-MMP | 0.982 | SR-p53 | 0.923 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.